These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29077146)

  • 41. High-sensitivity C-reactive protein and left ventricular remodeling in patients with acute myocardial infarction.
    Uehara K; Nomura M; Ozaki Y; Fujinaga H; Ikefuji H; Kimura M; Chikamori K; Nakaya Y; Ito S
    Heart Vessels; 2003 May; 18(2):67-74. PubMed ID: 12756602
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiac structure and function improvements in coronary artery disease combined with severe obstructive sleep apnea/hypopnea syndrome patients via noninvasive positive pressure ventilation therapy.
    Liu X; Feng L; Cao G; Huang H; Xu Q; Yu J; Zhang S; Zhou M
    Coron Artery Dis; 2014 Sep; 25(6):516-20. PubMed ID: 24870115
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of the intensive dose of rosuvastatin 40mg/day in patients with acute coronary syndrome and at high risk of cardiovascular disease-ROSUVEES-2.
    Shah CP; Shah BP; Dani SI; Channa BB; Lakshmanan SS; Krishnamani NC; Mehta A; Moorthy P
    Indian Heart J; 2016; 68(6):766-771. PubMed ID: 27931543
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of Rosuvastatin in Contrast-Induced Acute Kidney Injury in the Elderly: Post Hoc Analysis of the PRATO-ACS Trial.
    Tropeano F; Leoncini M; Toso A; Maioli M; Dabizzi L; Biagini D; Villani S; Bellandi F
    J Cardiovasc Pharmacol Ther; 2016 Mar; 21(2):159-66. PubMed ID: 26307206
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human recombinant-B-type natriuretic peptide protect ventricular function and structure in ST-elevation myocardial infarction.
    Gong X; Mou Z; Shao L; Zou Y; Gu Y; Sun S
    Int J Clin Exp Pathol; 2015; 8(9):11622-8. PubMed ID: 26617900
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.
    Sola S; Mir MQ; Lerakis S; Tandon N; Khan BV
    J Am Coll Cardiol; 2006 Jan; 47(2):332-7. PubMed ID: 16412856
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intensive statin therapy stabilizes C-reactive protein, but not chemokine in stable coronary artery disease treated with an everolimus-eluting stent.
    Sukegawa H; Maekawa Y; Yuasa S; Anzai A; Kodaira M; Takei M; Sano F; Ueda I; Kawakami T; Hayashida K; Kohno T; Kohsaka S; Abe T; Fukuda K
    Coron Artery Dis; 2016 Aug; 27(5):405-11. PubMed ID: 27105046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment Trends, Effectiveness, and Safety of Statins on Lipid Goal Attainment in Chinese Percutaneous Coronary Intervention Patients: a Multicenter, Retrospective Cohort Study.
    Chen Y; Li D; Jing J; Yan H; Liu J; Shen Z; James S; Varenhorst C
    Clin Ther; 2017 Sep; 39(9):1827-1839.e1. PubMed ID: 28807393
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of rosuvastatin as an adjuvant treatment for deep vein thrombosis.
    San Norberto EM; Gastambide MV; Taylor JH; García-Saiz I; Vaquero C
    Vasa; 2016; 45(2):133-40. PubMed ID: 27058799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of rosuvastatin and atorvastatin on nonsustained ventricular tachycardia in patients with ST-elevation myocardial infarction: a retrospective analysis.
    Hu X; Cheng J; Li C
    Eur J Clin Pharmacol; 2018 Jan; 74(1):29-35. PubMed ID: 28965256
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protection of Ivabradine Combined with Trimetazidine on Myocardial Injury after Percutaneous Coronary Intervention in Patients with Coronary Artery Disease Evaluated by Magnetic Resonance Image under Convolutional Neural Network.
    Chen C
    Contrast Media Mol Imaging; 2021; 2021():3150938. PubMed ID: 34629991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved cardiac performance by rosuvastatin is associated with attenuations in both myocardial tumor necrosis factor-alpha and p38 MAP kinase activity in rats after myocardial infarction.
    Xu Y; Tang T; Ding Y; Yao R; Xie J; Liao M; Xiao H; Chen Y; Yu X; Fu M; Liao Y; Zhao G; Cheng X
    Am J Med Sci; 2010 Aug; 340(2):121-7. PubMed ID: 20588182
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rosuvastatin slows the development of diastolic dysfunction in calcific aortic stenosis.
    Moura LM; Ramos SF; Kristensen SD; Pinto FJ; Barros IM; Rocha-Gonçalves F
    J Heart Valve Dis; 2012 Jul; 21(4):463-72. PubMed ID: 22953672
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of left ventricular ejection fraction on clinical long-term follow-up outcomes in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Wang CH; Xie XJ; Fang Q; Zhang SY; Fang ZJ; Jiang XF; Xie HZ; Liu ZY; Shen ZJ
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):265-8. PubMed ID: 21418873
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study.
    Rizos CV; Milionis HJ; Kostapanos MS; Florentin M; Kostara CE; Elisaf MS; Liberopoulos EN
    Clin Ther; 2010 Mar; 32(3):492-505. PubMed ID: 20399986
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of rosuvastatin dose-loading on serum sLox-1, hs-CRP, and postoperative prognosis in diabetic patients with acute coronary syndromes undergoing selected percutaneous coronary intervention (PCI).
    Jiao Y; Hu F; Zhang Z; Gong K; Sun X; Li A; Liu N
    Int J Clin Exp Med; 2015; 8(11):21565-71. PubMed ID: 26885106
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial.
    Colucci WS; Kolias TJ; Adams KF; Armstrong WF; Ghali JK; Gottlieb SS; Greenberg B; Klibaner MI; Kukin ML; Sugg JE;
    Circulation; 2007 Jul; 116(1):49-56. PubMed ID: 17576868
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rosuvastatin attenuates atrial structural remodelling in rats with myocardial infarction through the inhibition of the p38 MAPK signalling pathway.
    Wang M; Li Z; Zhang X; Xie X; Zhang Y; Wang X; Hou Y
    Heart Lung Circ; 2015 Apr; 24(4):386-94. PubMed ID: 25613240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The use of recombinant human B-type natriuretic peptide for the protection of cardiac and renal functions in heart failure patients with acute anterior myocardial infarction in peri-operative period of primary percutaneous coronary intervention].
    Zhang J; Fu XH; Fan XN; Jia XW; Gu XS; Li SQ; Jiang YF; Fan WZ; Su JL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Nov; 22(11):669-73. PubMed ID: 21122202
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis.
    McMurray JJ; Kjekshus J; Gullestad L; Dunselman P; Hjalmarson A; Wedel H; Lindberg M; Waagstein F; Grande P; Hradec J; Kamenský G; Korewicki J; Kuusi T; Mach F; Ranjith N; Wikstrand J;
    Circulation; 2009 Dec; 120(22):2188-96. PubMed ID: 19917888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.